Utssav CZ Gold (UTSSAV)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 67.09% and profit growth of 198.07% show strong momentum.
• P/E of 10.85 with a PEG of 0.08 suggests the market is pricing in very little future growth.
• ROCE of 21.80% indicates efficient capital use.
• Piotroski F-Score of 7/9 points to improving financial health.
• Promoter holding of 70.30% aligns management interests with minority shareholders.

Concerns

• Dividend yield is 0.00%, offering no cash return while growth consumes capital.
• Stock is down sharply from the 52-week high of ₹568.00 to ₹239.55, hinting at market scepticism.
• Book value, ROE, and debt/equity are unavailable, leaving balance sheet risk unclear.
• Gold and jewellery is a cyclical, competitive business without an obvious durable moat.

AI Analysis

At first glance, Utssav CZ Gold looks like a classic value-meets-growth situation. A P/E of 10.85 with sales growing 67.09% and profit growing 198.07% is the sort of asymmetry Graham would ask me to examine. With a PEG ratio of 0.08, the market appears to be paying almost nothing for the future. But I must be careful. The stock trades at ₹239.55, down sharply from its 52-week high of ₹568.00, so Mr Market is signalling something. The last quarter's sales of ₹475 Cr and net profit of ₹29 Cr show real business activity, but a jeweller selling gold and CZ is, at its core, a competitor in a cyclical, capital-intensive industry. I see no unassailable moat here; brands matter in jewellery, but pricing power is limited by bullion prices and consumer discretion. Promoters holding 70.30% is encouraging, and ROCE of 21.80% suggests decent capital allocation. The Piotroski score of 7/9 strengthens my confidence in the health of the numbers. However, I have no book value, ROE, or debt/equity ratio, so I cannot fully judge the balance sheet risk. I also dislike the 0.00% dividend yield; I like businesses that return cash, unless retained earnings are being deployed with high returns. The 198% profit growth appears extraordinary, but I have to ask: is it sustainable or just a sharp cyclical recovery? If the business can keep compounding with even half the recent growth, the current valuation is cheap. If the earnings reverse, the low P/E becomes a value trap. I would not bet my entire portfolio; I would start small and watch the next few quarters with discipline.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer